Poly-Histine CS Interactions
There are 667 drugs known to interact with Poly-Histine CS (brompheniramine / codeine / phenylpropanolamine), along with 25 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 159 are major, 504 are moderate, and 4 are minor.
- View all 667 medications that may interact with Poly-Histine CS
- View Poly-Histine CS alcohol/food interactions (2)
- View Poly-Histine CS disease interactions (25)
Most frequently checked interactions
View interaction reports for Poly-Histine CS (brompheniramine / codeine / phenylpropanolamine) and the medicines listed below.
- Aleve (naproxen)
- aluminum hydroxide / magnesium hydroxide / simethicone
- Aspir 81 (aspirin)
- Bactroban (mupirocin topical)
- KCl (potassium chloride)
- Lasix (furosemide)
- Levaquin (levofloxacin)
- metoprolol
- Tessalon Perles (benzonatate)
- Tobrex (tobramycin ophthalmic)
- Tylenol (acetaminophen)
- Zantac (ranitidine)
Poly-Histine CS alcohol/food interactions
There are 2 alcohol/food interactions with Poly-Histine CS (brompheniramine / codeine / phenylpropanolamine).
Poly-Histine CS disease interactions
There are 25 disease interactions with Poly-Histine CS (brompheniramine / codeine / phenylpropanolamine) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
- psychosis
- BPH
- diabetes
- glaucoma
Report options
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.